News | March 16, 2024
Evonik makes five generations healthier with EUDRAGIT coatings for targeted drug delivery
More than 10,000 scientific publications containing EUDRAGIT
More than 10,000 scientific publications containing EUDRAGIT
Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Launches collaborative centre for translational research in head and neck cancer
About 75% of all primary liver cancers in adults are HCC and up to 30% of HCC patients are eligible for embolisation
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Commenced operations in flood-affected Himachal Pradesh
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
Subscribe To Our Newsletter & Stay Updated
